Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection: Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program
Elisabetta Teti(University of Rome Tor Vergata), Massimo Andreoni(University of Rome Tor Vergata), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Massimo Galli(Luigi Sacco Hospital), Gioacchino Angarano(University of Bari Aldo Moro), Elisa Gentilotti(University of Verona), Loredana Sarmati(University of Rome Tor Vergata), Adriano Lazzarin(Vita-Salute San Raffaele University), Alfredo Pennica(Azienda Ospedaliera Sant'Andrea), Andrea De Luca(Agostino Gemelli University Polyclinic), Nicola Boffa(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Claudio Maria Mastroianni(Sapienza University of Rome), Andrea Antinori(Heinrich Heine University Düsseldorf), Anna Maria Cattelan(University of Padua), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), C Mussini(Azienda Ospedaliero-Universitaria di Modena), Francesco Castelli(Trieste Astronomical Observatory), Gloria Taliani(Sapienza University of Rome), Raffaele Bruno(University of Pavia), Giustino Parruti(Azienda USL di Pescara), Alessandra Ricciardi(University of Rome Tor Vergata), L. Sighinolgi(University of Ferrara), Antonio Chirianni(Université Ouaga II), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Bruno Cacopardo(University of Catania), Andrea Giacometti(Marche Polytechnic University), A. D’Arminio Monforte(University of Milan), Anna Maria Gori(Azienda Ospedaliero-Universitaria Careggi), Giuliano Rizzardini(Luigi Sacco Hospital), Antonio Di Biagio, Vincenzo Vullo(Policlinico Umberto I), Giampaolo Perri(Ospedale Amedeo di Savoia)
Cited by 7
Related Papers
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
|Journal of the American College of Cardiology|2007|656
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653